Kwang Woo Kim

Title: The Innovative Contributions of Kwang Woo Kim

Introduction

Kwang Woo Kim is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable liquid formulations for antibodies. With a total of five patents to his name, Kim's work is paving the way for advancements in medical treatments.

Latest Patents

Among his latest patents is a stable liquid pharmaceutical formulation of an anti-influenza virus antibody. This formulation includes an anti-influenza virus antibody or a mixture of different types of antibodies, a surfactant, a sugar or sugar derivative, and an amino acid. The preparation boasts excellent storage stability at various temperatures, making it suitable for multiple administration routes. Another notable patent is a stable liquid formula comprising an anti-TNFa antibody, an acetate buffer, glycine, and a surfactant. This formulation remains stable even with high antibody content and allows for subcutaneous administration.

Career Highlights

Kwang Woo Kim is currently employed at Celltrion Inc., a leading biopharmaceutical company. His work focuses on creating innovative solutions that enhance the efficacy and stability of pharmaceutical products. His contributions have been instrumental in advancing the field of antibody therapies.

Collaborations

Kim collaborates with talented professionals in his field, including Joon Won Lee and Yeon Kyeong Shin. Their combined expertise fosters an environment of innovation and excellence in pharmaceutical research.

Conclusion

Kwang Woo Kim's innovative work in developing stable liquid formulations for antibodies highlights his significant impact on the pharmaceutical industry. His patents reflect a commitment to improving medical treatments and patient care.